$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
卡非佐米多少钱一个疗程?
2025-10-19 11:44:20
Check Details
卡非佐米在医保范围内吗?
2025-10-19 11:44:20
Check Details
卡非佐米医保后的价格
2025-10-19 11:44:20
Check Details
卡非佐米适用于什么病症?
2025-10-19 11:44:20
Check Details
卡非佐米疗效怎么样?
2025-10-19 11:44:20
Check Details
卡非佐米用途和效果
2025-10-19 11:44:20
Check Details
卡非佐米治疗多发性骨髓瘤的效果
2025-10-19 11:44:20
Check Details
卡非佐米安全性及疗效
2025-10-19 11:44:20
Check Details
雷利度胺治疗骨髓增生异常综合症效果
2025-10-19 11:44:20
Check Details
雷利度胺的使用方法
2025-10-19 11:44:20
Check Details
雷利度胺用法用量
2025-10-19 11:44:20
Check Details
雷利度胺对多发性骨髓瘤的疗效
2025-10-19 11:44:20
Check Details
1
2
...
1130
1131
1132
1133
1134
1135
1136
...
4158
4159
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Alpelisib vs Inavolisib: How to Choose Between Two PI3Kα Inhibitors in PIK3CA-Mutated Breast Cancer
2
Selumetinib: The First MEK1/2 Inhibitor Approved for Inoperable Plexiform Neurofibromas in NF1
3
FIGHT-302 Phase 3 Trial: First-Line Pemigatinib Significantly Improves PFS Over Chemotherapy in FGFR2-Rearranged Cholangiocarcinoma
4
Selpercatinib Dosing Guide: Weight-Based Precision Targeting for RET-Driven Tumors
5
Mitotane Side Effects: Understanding Key Risks in Adrenocortical Carcinoma Therapy
6
Axitinib: Indications, Mechanism of Action & Key Safety Warnings
7
Capmatinib Generic Guide: Laos Version Availability, Efficacy & Safety Overview
8
Eltrombopag Administration Timing and Alternative Therapy Guide
9
Osimertinib Safety Guide: Foods to Avoid, Mechanism of Action, and Pre-Treatment Warnings
10
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
11
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
12
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies